These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 18616956)
1. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats. de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S; Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956 [TBL] [Abstract][Full Text] [Related]
2. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors. Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Suplita RL; Farthing JN; Gutierrez T; Hohmann AG Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456 [TBL] [Abstract][Full Text] [Related]
4. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279 [TBL] [Abstract][Full Text] [Related]
5. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920 [TBL] [Abstract][Full Text] [Related]
6. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus. Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049 [TBL] [Abstract][Full Text] [Related]
7. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997 [TBL] [Abstract][Full Text] [Related]
8. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581 [TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant effects of N-arachidonoyl-serotonin, a dual fatty acid amide hydrolase enzyme and transient receptor potential vanilloid type-1 (TRPV1) channel blocker, on experimental seizures: the roles of cannabinoid CB1 receptors and TRPV1 channels. Vilela LR; Medeiros DC; de Oliveira AC; Moraes MF; Moreira FA Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):330-4. PubMed ID: 24674273 [TBL] [Abstract][Full Text] [Related]
10. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871 [TBL] [Abstract][Full Text] [Related]
11. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230 [TBL] [Abstract][Full Text] [Related]
12. Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). Bashashati M; Fichna J; Piscitelli F; Capasso R; Izzo AA; Sibaev A; Timmermans JP; Cenac N; Vergnolle N; Di Marzo V; Storr M Neurogastroenterol Motil; 2017 Dec; 29(12):. PubMed ID: 28695708 [TBL] [Abstract][Full Text] [Related]
13. The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. de Novellis V; Vita D; Gatta L; Luongo L; Bellini G; De Chiaro M; Marabese I; Siniscalco D; Boccella S; Piscitelli F; Di Marzo V; Palazzo E; Rossi F; Maione S Mol Pain; 2011 Jan; 7():7. PubMed ID: 21241462 [TBL] [Abstract][Full Text] [Related]
14. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia. Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510 [TBL] [Abstract][Full Text] [Related]
15. Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity. de Novellis V; Luongo L; Guida F; Cristino L; Palazzo E; Russo R; Marabese I; D'Agostino G; Calignano A; Rossi F; Di Marzo V; Maione S Eur J Pharmacol; 2012 Feb; 676(1-3):41-50. PubMed ID: 22178921 [TBL] [Abstract][Full Text] [Related]
16. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat. de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687 [TBL] [Abstract][Full Text] [Related]
17. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. Starowicz K; Maione S; Cristino L; Palazzo E; Marabese I; Rossi F; de Novellis V; Di Marzo V J Neurosci; 2007 Dec; 27(50):13739-49. PubMed ID: 18077685 [TBL] [Abstract][Full Text] [Related]
18. New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. Ortar G; Cascio MG; De Petrocellis L; Morera E; Rossi F; Schiano-Moriello A; Nalli M; de Novellis V; Woodward DF; Maione S; Di Marzo V J Med Chem; 2007 Dec; 50(26):6554-69. PubMed ID: 18027904 [TBL] [Abstract][Full Text] [Related]
19. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats. Pardo-García TR; Yusif-Rodriguez N; Yudowski G; Maldonado-Vlaar CS Neurosci Lett; 2020 Jul; 732():135023. PubMed ID: 32422166 [TBL] [Abstract][Full Text] [Related]
20. Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy. Silva M; Martins D; Charrua A; Piscitelli F; Tavares I; Morgado C; Di Marzo V Neuropharmacology; 2016 Aug; 107():49-57. PubMed ID: 26965218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]